Combining two existing cancer drugs could offer promise for some children with an incurable childhood brain cancer, a new study suggests.

Scientists have used artificial intelligence-enhanced tools to successfully propose a new combination of drugs for use against an incurable childhood brain cancer.

Scientists at The Institute of Cancer Research are working with Healx, a biotech company specialising in artificial intelligence (AI) to discover new possible ways of treating diffuse intrinsic pontine glioma (DIPG), an essentially untreatable brain cancer in children.​